NasdaqCM - Delayed Quote USD

OptimizeRx Corporation (OPRX)

Compare
5.36
-0.05
(-0.92%)
At close: January 10 at 4:00:01 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen L. Silvestro President & Interim CEO 591.62k -- 1979
Mr. Edward Stelmakh C.M.A., M.B.A. CFO & COO 626.74k -- 1966
Mr. Andrew Jacob D'Silva Senior Vice President of Corporate Finance -- -- --
Ms. Marion K Odence-Ford General Counsel & Chief Compliance Officer 428.12k -- 1965
Ms. Maira Alejandra Media Relations Manager -- -- --
Ms. Sheryl Kearney Human Resources Manager -- -- --
Mr. Terence J. Hamilton Senior Vice President of Pharma 441.63k -- 1965
Dr. Doug Besch Chief Product Officer -- -- 1982
Ms. Theresa Greco Chief Commercial Officer -- -- --
Mr. Brian Clark McCarthy Chief Revenue Officer -- -- --

OptimizeRx Corporation

260 Charles Street
Suite 302
Waltham, MA 02453
United States
248-651-6568 https://www.optimizerx.com
Sector: 
Healthcare
Full Time Employees: 
135

Description

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Corporate Governance

OptimizeRx Corporation’s ISS Governance QualityScore as of January 1, 2025 is 8. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 4; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 26, 2025 at 12:30 PM UTC - March 31, 2025 at 12:30 PM UTC

OptimizeRx Corporation Earnings Date

Recent Events

January 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 15, 2024 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

August 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 23, 2024 at 12:00 AM UTC

S-8 POS: Offering Registrations

June 18, 2024 at 12:00 AM UTC

S-8: Offering Registrations

June 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers